US Patent

US8039504 — Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

Formulation · Assigned to Siga Technologies Inc · Expires 2027-07-23 · 1y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects methods and compositions for treating or preventing viral infections and diseases caused by the orthopoxvirus.

USPTO Abstract

Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases cased by the orthopoxvirus.

Drugs covered by this patent

Patent Metadata

Patent number: US8039504
Jurisdiction: US
Classification: Formulation
Expires: 2027-07-23
Drug substance claim: No
Drug product claim: Yes
Assignee: Siga Technologies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.